MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software, and music to measure and improve walking, today announced the advancement of its pipeline in multiple sclerosis (MS) and Parkinson's disease (PD). As part of [...]
The Digital Therapeutics Alliance (DTA) is pleased to welcome the following individuals to the DTA Board of Directors: Peter Hames, Co-Founder and CEO, Big Health Anand Iyer, Chief Strategy Officer, WellDoc Pierre Leurent, Founder and [...]
Pear Therapeutics, Inc., the leader in Prescription Digital Therapeutics (PDTs), announced today that it has entered into agreements with multiple technology innovators, including Firsthand Technology, Inc., leading researchers from the Karolinska Institute in Sweden, Cincinnati [...]
Our industry-first Digital Health Formulary will allow employers and health plans to manage this fast-growing segment of health care while improving access for patients. As more people turn to digital programs to help manage serious [...]
The study, which was presented at the Meeting of the American College of Neuropsychopharmacology yesterday, found that patients using the technology improved their sustained attention compared to those in the control group.
Astellas Pharma Inc. and Welldoc, Inc. today announced that the companies have entered into a collaboration and license agreement directed toward the development and commercialization of digital health solutions. Under the agreement, Astellas and Welldoc [...]
Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite [...]
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting ("DTM") conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose [...]
Deepening a collaboration that began in 2013, Omada Health and Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the availability of Omada’s Type 2 Diabetes Digital Care program as a covered benefit [...]
Trust is crucial as patients increasingly use digital therapeutic products for the delivery of high quality, evidence-based medical treatments Washington, D.C. — Today, the Digital Therapeutics Alliance (DTA) released an Industry Code of Ethics, a [...]